Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort studyBMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b2942 (Published 19 August 2009) Cite this as: BMJ 2009;339:b2942
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial